Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3692]

Atomic structure of major cancer drug target cracked

Atomic structure of major cancer drug target cracked

Patients with resectable oesophageal adenocarcinoma benefit from neoadjuvant chemoradiotherapy

Patients with resectable oesophageal adenocarcinoma benefit from neoadjuvant chemoradiotherapy

Second round of gefitinib may be promising lung cancer therapy

Second round of gefitinib may be promising lung cancer therapy

Drug with unique disruption of tumour blood flow shows promise

Drug with unique disruption of tumour blood flow shows promise

Gene testing identifies lung cancer patients who benefit from ALK-inhibitor drug

Gene testing identifies lung cancer patients who benefit from ALK-inhibitor drug

MicroRNA profiling identifies chemoresistance in Small Cell Lung Cancer

MicroRNA profiling identifies chemoresistance in Small Cell Lung Cancer

Further analysis of BIG 1-98 shows overall survival benefit of letrozole compared with tamoxifen

Further analysis of BIG 1-98 shows overall survival benefit of letrozole compared with tamoxifen

Three oesophageal cancer cell lines commonly used in research prove to be from other cancers

Three oesophageal cancer cell lines commonly used in research prove to be from other cancers

Update on hormonal therapy for metastatic breast cancer

Update on hormonal therapy for metastatic breast cancer

Obesity linked to clear-cell renal cell cancer

Obesity linked to clear-cell renal cell cancer

More from ecancer